1.7 semaglutide Active ingredient in Ozempic, Wegovy shows early promise for treating alcohol use disorder among those with obesity: Study Wegovy (semaglutide) Injector 1.7 mg/0.75 mL Semasize 1.7 semaglutide pen at

What was studied: The incidence of major adverse cardiovascular events Outcome: Semaglutide reduced the relative risk of adverse cardiovascular events by 20%, translating to an absolute reduction of 1.5 percentage points, from 8.0% in placebo participants to 6.5% in semaglutide participants

For people who are curious about GLP-1s but want to start slowly, Nooms Microdose GLP-1 program may be a helpful first step

What Is the Active Ingredient in Semaglutide Injections

CivicSciences GLP-1 Consumer Tracker offers unparalleled insight into how these medications are reshaping consumer behavior and impacting countless industries.

Indications The main indication of Ozempic (Semaglutide) 2 mg/3 ml is to help adults with type 2 diabetes mellitus regulate their blood glucose levels and keep control of them